Division of Cannabis Regulation Notice of Recall
August 8, 2024
Topic: Notice of Mandatory Marijuana Product Recall
Issue: The Division of Cannabis Regulation (DCR) is issuing an alert to patients and consumers about a mandatory product recall. Pursuant to 19 CSR 100-1.100(4)(P), DCR may issue a public notice of recall where marijuana product presents a potential threat to health and safety.
DCR is issuing a product recall on marijuana products sold to dispensary and manufacturing facilities by comprehensive manufacturing licensee C&C Manufacturing, LLC, MAN000105. The recalled products were not compliantly tracked in the statewide track and trace system (Metrc) as mandated by 19 CSR 100-1. Therefore, DCR cannot verify compliance with health and safety requirements.
Affected Products: The list of recalled products is located at Product Recalls.
No adverse reactions for this product have been reported to DCR at this time.
Patients and consumers who have purchased the recalled product should discontinue use. All unused product(s) should be discarded or returned to the dispensary facility where purchased. Returned products will not count toward a patient’s purchase limit. For more information on returns, please contact the dispensary facility where the product was purchased. For information on recalled items, please go to Product Recalls.
Anyone who thinks that they may be experiencing adverse reactions should seek immediate medical attention. Patients and consumers are reminded that any adverse reactions should be reported to CannabisComplaints@health.mo.gov or fill out a complaint form located here.
Andrea Balkenbush, Deputy Director
Division of Cannabis Regulation
Department of Health and Senior Services